| Aug 18 2021 |
Hemp Industry Submits Comments on Draft CAOA |
Keller and Heckman LLP |
| Aug 18 2021 |
Six Things You Need to Know About CBD and Other Hemp-containing Pet Products |
Womble Bond Dickinson (US) LLP |
| Aug 17 2021 |
Another Florida Mini-TCPA Class Action Filed – This Time Against Pizza Hut |
Troutman Amin, LLP |
| Aug 17 2021 |
PhRMA Updates its Code on Interactions with Health Care Professionals in Response to the OIG's Special Fraud Alert on Speaker Programs |
Mintz |
| Aug 17 2021 |
Pennsylvania Court Holds Medical Marijuana Act Allows Employees to Sue for Discrimination |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Aug 17 2021 |
New Vaccine Requirements for Federal Contractors |
Bradley Arant Boult Cummings LLP |
| Aug 17 2021 |
Taking Advantage of Medicare Advantage: Medicare Part C Fraud |
Tycko & Zavareei LLP |
| Aug 17 2021 |
Senate Bill Targets CA’s Animal Welfare Law |
Keller and Heckman LLP |
| Aug 17 2021 |
Marijuana Legalization Rundown: New Legislation Across Several States |
Epstein Becker & Green, P.C. |
| Aug 16 2021 |
Pennsylvania Appellate Court Affirms State Medical Marijuana Law Provides Private Right Of Action |
Jackson Lewis P.C. |
| Aug 16 2021 |
FDA Reaffirms Need for More Safety Data on CBD |
Keller and Heckman LLP |
| Aug 16 2021 |
Another Battle in the Political Fight Over How to Address High Drug Prices |
Mintz |
| Aug 13 2021 |
Running Down the Field of Sports Performance Drinks with Terrell Davis and Megan Bushell from DEFY [PODCAST] |
Greenberg Traurig, LLP |
| Aug 13 2021 |
EU Revises Lead and Cadmium Limits |
Keller and Heckman LLP |
| Aug 13 2021 |
EFSA Publishes Safety Assessment of Silver Nanoparticles Intended to Be Used in Plastics |
Bergeson & Campbell, P.C. |
| Aug 13 2021 |
5 Keys to Passing an FDA Inspection or Audit |
Oberheiden P.C. |
| Aug 13 2021 |
PhRMA Code Update Clarifies and Tightens Key Provisions Associated with Speaker Programs |
Foley & Lardner LLP |
| Aug 12 2021 |
New York and New Jersey Legalize Recreational Marijuana: Still, Immigrants Might Face Risks |
Norris McLaughlin P.A. |
| Aug 12 2021 |
The Rise and Fall of “Vanilla” Labeling Challenges |
Proskauer Rose LLP |
| Aug 12 2021 |
Legal Victory for “Vegan Butter” |
Keller and Heckman LLP |
| Aug 12 2021 |
The Skinny Label That Wasn’t—Federal Circuit Reinstates Induced Infringement Verdict |
McDermott Will & Schulte LLP |
| Aug 11 2021 |
“Champion” Petfoods: Seventh Circuit Affirms Dismissal of False Advertising Suit Against Pet Food Company |
Proskauer Rose LLP |
| Aug 11 2021 |
California Amends Olive Oil Labeling Bill |
Keller and Heckman LLP |
| Aug 10 2021 |
Consumers Allegedly Deceived by Sugar Claims |
Keller and Heckman LLP |
| Aug 10 2021 |
CMS Proposes to Rescind Most Favored Nation Drug Pricing Rule |
K&L Gates LLP |
| Aug 10 2021 |
Let it “Bee”: Ninth Circuit Affirms Dismissal of Trader Joe’s Manuka Honey Advertising Suit |
Proskauer Rose LLP |
| Aug 10 2021 |
The Hot Coffee Case Revisited: Has Proximate Cause Changed in the 25 Years Since Liebeck v. McDonald’s Restaurants? |
ArentFox Schiff LLP |
| Aug 10 2021 |
Securities Litigation Update: First Circuit Holds That Future-Focused Risk Disclosures Are Not Misleading Absent “Grand Canyon”-Level Threat to Company |
Cadwalader, Wickersham & Taft LLP |
| Aug 9 2021 |
House Bill Would Require FDA to Study and Reassess Chemicals Used in Food |
Bergeson & Campbell, P.C. |
| Aug 9 2021 |
California Breaks New Ground With OCal: Answers to Key Questions About “Comparable-to-Organic” Cannabis |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 6 2021 |
Legislative Update for the Tribal Cannabis Industry |
Van Ness Feldman LLP |
| Aug 6 2021 |
EFSA Updates Guidance on Nanomaterials Risk Assessment to Be Applied in Food and Feed Chain: Human and Animal Health |
Bergeson & Campbell, P.C. |
| Aug 6 2021 |
CFIA Update on Simulated Meat and Poultry Proposal |
Keller and Heckman LLP |
| Aug 6 2021 |
The End is Near for North Carolina's Hemp Pilot Program |
Ward and Smith, P.A. |
| Aug 5 2021 |
EPA Will Delay 1,4-Dioxane Risk Management until Nearing Completion of Reconsideration of Risk Evaluation |
Bergeson & Campbell, P.C. |
